GPCR Structure Therapeutics Inc. American
Company Analysis
Latest News
🟢 Structure Therapeutics is trading 4.3% up today amid easing insider-selling concerns
Structure Therapeutics is trading at $48.00 (4.3%) up in after-hours trading as investors reassess recent volatility tied to insider selling and...
🔴 Structure Therapeutics is trading 4.2% down today amid CSO's recent share sales and profit-taking
Structure Therapeutics is trading 4.2% down at $47.52 as investors react to recent insider selling and engage in profit-taking following a major rally tied to...
🟢 Structure Therapeutics is trading 4.9% up today, rebounding after profit taking following positive obesity drug data
Structure Therapeutics is trading 4.9% higher at $54.14 in pre-market action, staging a partial recovery after two consecutive sessions of profit taking. •...
🔴 Structure Therapeutics is trading 4.1% down today on continued profit-taking after obesity-drug rally
Structure Therapeutics is trading 4.1% down now at $51.19 as investors continue to lock in gains after a powerful rally driven by bullish oral GLP-1 obesity...
🔴 Structure Therapeutics is trading 4.2% down today on profit-taking after obesity-drug rally and acquisition rumors
Structure Therapeutics is trading 4.2% down at $52.84 as investors take profits following a sharp multi-month rally driven by positive oral obesity-drug data...
🔴 Structure Therapeutics is trading 8.2% down today as investors take profits following a strong obesity-pill rally
Structure Therapeutics is trading 8.2% down at $50.64 in pre-market, pulling back after a multi-month rally fueled by positive obesity-pill data and...
🔴 GPCR is trading 4.4% down today amid biotech selloff and analyst price target cut
GPCR is trading 4.4% down at $54.16 amid broader weakness in risk assets and cautious sentiment across the biotechnology sector. • H.C. Wainwright recently...